The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes von Baven‐Pronk, A. M. C., Coenraad, M. J., van Buuren, H. R., de Man, R. A., van Erpecum, K. J., Lamers, M. M. H., Drenth, J. P. H., van den Berg, A. P., Beuers, U. H., den Ouden, J., Koek, G. H., van Nieuwkerk, C. M. J., Bouma, G., Brouwer, J. T., van Hoek, B.

Volltext

HLA-DRB103:01 and HLA-DRB104:01 modify the presentation and outcome in autoimmune hepatitis type-1 von van Gerven, N M F, de Boer, Y S, Zwiers, A, Verwer, B J, Drenth, J P H, van Hoek, B, van Erpecum, K J, Beuers, U, van Buuren, H R, den Ouden, J W, Verdonk, R C, Koek, G H, Brouwer, J T, Guichelaar, M M J, Vrolijk, J M, Coenraad, M J, Kraal, G, Mulder, C J J, van Nieuwkerk, C M J, Bloemena, E, Verspaget, H W, Kumar, V, Zhernakova, A, Wijmenga, C, Franke, L, Bouma, G

Volltext

Intra-gastric balloon with lifestyle modification: a promising therapeutic option for overweight and obese patients with metabolic dysfunction-associated steatotic liver disease von van Dijk, A. M., de Vries, M., El-Morabit, F., Bac, S. T., Mundt, M. W., van der Schuit, L. E., Hirdes, M. M. C., Kara, M., de Bruijne, J., van Meer, S., Kaasjager, H. A. H., de Valk, H. W., Vleggaar, F. P., van Erpecum, K. J.

Volltext

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease von Gadaleta, Raffaella M, van Erpecum, Karel J, Oldenburg, Bas, Willemsen, Ellen C L, Renooij, Willem, Murzilli, Stefania, Klomp, Leo W J, Siersema, Peter D, Schipper, Marguerite E I, Danese, Silvio, Penna, Giuseppe, Laverny, Gilles, Adorini, Luciano, Moschetta, Antonio, Mil, Saskia W C van

Volltext

Dutch guidance for the treatment of chronic hepatitis C virus infection in a new therapeutic era von Berden, F A C, Kievit, W, Baak, L C, Bakker, C M, Beuers, U, Boucher, C A B, Brouwer, J T, Burger, D M, van Erpecum, K J L, van Hoek, B, Hoepelman, A I M, Honkoop, P, Kerbert-Dreteler, M J, de Knegt, R J, Koek, G H, van Nieuwkerk, C M J, van Soest, H, Tan, A C I T L, Vrolijk, J M, Drenth, J P H

Volltext

ELF-test less accurately identifies liver cirrhosis diagnosed by liver stiffness measurement in non-Asian women with chronic hepatitis B von Harkisoen, S, Boland, G.J, van den Hoek, J.A.R, van Erpecum, K.J, Hoepelman, A.I.M, Arends, J.E

Volltext

Patients’ misconceptions about surveillance for hepatocellular carcinoma: Education is needed von van Meer, S, Lieveld, F.I, van Erpecum, K.J

Volltext

Stauffer's syndrome: A true entity? von van Roekel, C., Slot, A.S. Bruins, Viddeleer, A.C., van Erpecum, K.J., Lock, M.T.W.T.

Volltext

Indomethacin enhances bile salt detergent activity : Relevance for NSAIDs-induced gastrointestinal mucosal injury von PETRUZZELLI, M, MOSCHETTA, A, RENOOIJ, W, DE SMET, M. B. M, PALASCIANO, G, PORTINCASA, P, VAN ERPECUM, K. J

Volltext

Fatal N-Butyl-2-Cyanoacrylate Pulmonary Embolism after Sclerotherapy for Variceal Bleeding von van Beek, A. P., van Erpecum, K. J.

Volltext

The 2012 revised Dutch national guidelines for the treatment of chronic hepatitis B virus infection von BUSTER, E. H. C. J, BAAK, B. C, KOEK, G. H, VAN NIEUWKERK, K. M. J, SOEST, H. Van, VAN DER SPEK, B. W, TAN, A. C. I. T. L, VROLIJK, J. M, JANSSEN, H. L. A, BAKKER, C. M, BEUERS, U. H. W, BROUWER, J. T, DRENTH, J. P. H, VAN ERPECUM, K. J, HOEK, B. Van, HONKOOP, P, KERBERT-DRETELER, M. J

Volltext

Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non‐invasive assessment of liver fibrosis using transient elastography von POSTHOUWER, D., MAUSER‐BUNSCHOTEN, E. P., FISCHER, K., VAN ERPECUM, K. J., DE KNEGT, R. J.

Volltext

Durable response in the markers of cholestasis through 5 years of open-label extension study of obeticholic acid in primary biliary cholangitis von Nevens, F., Shiffman, M.L., Drenth, J.P.H., Bowlus, C.L., Vargas, V., Andreone, P., van Erpecum, K., Floreani, A., Liberman, A., Pencek, R., Malecha, E. Smoot, MacConell, L., Trauner, M.

Volltext

Ribavirin rather than PEG-interferon pharmacodynamics predict nonresponse to antiviral therapy in naive chronic hepatitis C patients von van Vlerken, L. G., Huisman, E. J., van Soest, H., Boland, G. J., Drenth, J. P. H., Siersema, P. D., Burger, D. M., van Erpecum, K. J.

Volltext

Valproic acid-induced DRESS syndrome with acute liver failure von VAN ZOELEN, M. A. D, DE GRAAF, M, DIJK, M. R. Van, BOGTE, A, ERPECUM, K. J. Van, ROCKMANN, H, MAARSCHALK-ELLERBROEK, L. J

Volltext

Ribavirin steady‐state plasma level is a predictor of sustained virological response in hepatitis C–infected patients treated with direct‐acting antivirals von Tilborg, M., Lieveld, F. I., Smolders, E. J., Erpecum, K. J., Kanter, C. T. M. M., Maan, R., Valk, M., Arends, J. E., Dofferhoff, A. S. M., Blokzijl, H., Bijmolen, M., Drenth, J. P. H., Knegt, R. J., Burger, D. M.

Volltext

Daclatasvir/peginterferon lambda-1a/ribavirin in patients with chronic HCV infection and haemophilia who are treatment naïve or prior relapsers to peginterferon alfa-2a/ribavirin von Santagostino, E., Pol, S., Olveira, A., Reesink, H. W., van Erpecum, K., Bogomolov, P., Xu, D., Critelli, L., Srinivasan, S., Cooney, E.

Volltext

Treatment of chronic hepatitis B virus infection : Dutch national guidelines von BUSTER, E. H. C. J, VAN ERPECUM, K. J, SCHALM, S. W, ZAAIJER, H. L, BROUWER, J. T, CELDERBLOM, H. C, DE KNEGT, R. J, MINKE BAKKER, C, REESINK, H. W, JANSSEN, H. L. A

Volltext

Severe impairment of postprandial cholecystokinin release and gall‐bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR von Moschetta, A., Stolk, M. F. J., Rehfeld, J. F., Portincasa, P., Slee, P. H. TH. J., Koppeschaar, H. P. F., Van Erpecum, K. J., Vanberge‐Henegouwen, G. P.

Volltext

Predictors for successful downstaging in patients with BCLC intermediate stage hepatocellular carcinoma von Broekhoven, A, Takkenberg, B, Sprengers, D, Ramsoekh, S, van Erpecum, K, van Meer, S, Verspaget, H, Burgmans, M, Osanto, S, Baranski, A, Fiocco, M, Coenraad, M

Volltext